JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Domino, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Domino, E. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 115, Issue 4, 449-463, 1955
Copyright © 1955 by American Society for Pharmacology and Experimental Therapeutics


A PHARMACOLOGICAL ANALYSIS OF THE FUNCTIONAL RELATIONSHIP BETWEEN THE BRAIN STEM AROUSAL AND DIFFUSE THALAMIC PROJECTION SYSTEMS

Edward F. Domino 1

1 Department of Pharmacology, University of Michigan, Ann Arbor

The effects of drugs with known degrees of selectivity in depressing polysynaptic pathways in the spinal cord were determined on the polysynaptic circuits involved in EEG arousal and recruitment. Arousal and recruiting responses elicited from the midbrain reticular formation and the diffuse thalamic projection system differed markedly in sensitivity to ethyl ether, pentobarbital, and mephenesin.

Presumptive evidence is presented on which is based a working hypothesis of the existence in the brain stem reticular formation of an ascending deactivating or inhibitory system.

Submitted on July 20, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1955 by the American Society for Pharmacology and Experimental Therapeutics.